Nanotoxicology
Volume 13, 2019 - Issue 1
Open access
3,948
Views
36
CrossRef citations to date
0
Altmetric
Review Articles
Preclinical hazard evaluation strategy for nanomedicines
Stefan SiegristDivision of Pharmaceutical Technology, Pharmacenter, University of Basel, Basel, Switzerland; View further author information
, Emre CörekDivision of Pharmaceutical Technology, Pharmacenter, University of Basel, Basel, Switzerland; View further author information
, Pascal DetampelDivision of Pharmaceutical Technology, Pharmacenter, University of Basel, Basel, Switzerland; View further author information
, Jenny SandströmSwiss Centre for Applied Human Toxicology, Basel, Switzerland; View further author information
, Peter WickLaboratory for Patricles-Biology Interactions, Empa Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, SwitzerlandView further author information
& Jörg HuwylerDivision of Pharmaceutical Technology, Pharmacenter, University of Basel, Basel, Switzerland; Correspondence[email protected]
View further author information
View further author information
Pages 73-99
|
Received 03 May 2018, Accepted 20 Jul 2018, Published online: 05 Sep 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.